Cargando…

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study

INTRODUCTION: Earlier antiretroviral therapy (ART) initiation reduces HIV-1 incidence. This benefit may be offset by increased transmitted drug resistance (TDR), which could limit future HIV treatment options. We analyze the epidemiological impact and cost-effectiveness of strategies to reduce TDR....

Descripción completa

Detalles Bibliográficos
Autores principales:	Nichols, Brooke E, Sigaloff, Kim CE, Kityo, Cissy, Hamers, Raph L, Baltussen, Rob, Bertagnolio, Silvia, Jordan, Michael R, Hallett, Timothy B, Boucher, Charles AB, de Wit, Tobias F Rinke, van de Vijver, David AMC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260459/ https://www.ncbi.nlm.nih.gov/pubmed/25491351 http://dx.doi.org/10.7448/IAS.17.1.19164

Ejemplares similares

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study
por: Boender, T. Sonia, et al.
Publicado: (2012)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Inzaule, Seth C., et al.
Publicado: (2018)

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure
por: Boerma, Ragna S., et al.
Publicado: (2017)

Epidemiological impact and cost‐effectiveness of providing long‐acting pre‐exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study
por: van Vliet, Marjolein M, et al.
Publicado: (2019)

Pre-treatment HIV drug resistance testing cost-effectiveness
por: van de Vijver, David AMC, et al.
Publicado: (2020)

Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique
por: Lamorde, Mohammed, et al.
Publicado: (2014)

Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
por: Kroeze, Stefanie, et al.
Publicado: (2019)

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts
por: Bijker, Rimke, et al.
Publicado: (2017)

Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review
por: Hamers, Raph L, et al.
Publicado: (2022)

Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa
por: Faria, Nuno R., et al.
Publicado: (2019)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation
por: Ogbenna, Ann Abiola, et al.
Publicado: (2020)

Sequencing paediatric antiretroviral therapy in the context of a public health approach
por: Boerma, Ragna S, et al.
Publicado: (2015)

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017)

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda
por: Balinda, Sheila N., et al.
Publicado: (2016)

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
por: Hamers, Raph L, et al.
Publicado: (2012)

Quality of life among people living with HIV in England and the Netherlands: a population-based study
por: Popping, Stephanie, et al.
Publicado: (2021)

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study
por: Nichols, Brooke E., et al.
Publicado: (2013)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
por: Paton, Nicholas I, et al.
Publicado: (2017)

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study
por: Nichols, Brooke E., et al.
Publicado: (2015)

Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study
por: Baltussen, Rob, et al.
Publicado: (2012)

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving
por: Popping, Stephanie, et al.
Publicado: (2019)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
por: Popping, Stephanie, et al.
Publicado: (2018)

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2012)

A qualitative study of barriers to antimicrobial stewardship in Indonesian hospitals: governance, competing interests, cost, and structural vulnerability
por: Limato, Ralalicia, et al.
Publicado: (2022)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study
por: Gomo, Zvenyika AR, et al.
Publicado: (2014)

Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study
por: Ginsberg, Gary M, et al.
Publicado: (2012)

High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
por: Boerma, Ragna S, et al.
Publicado: (2016)

Education in Mathematics and the Spread of COVID-19
por: Ang, Joshua Ping, et al.
Publicado: (2021)

Mathematical Model of the Spread of Hantavirus Infection
por: Gutiérrez-Jara, Juan Pablo, et al.
Publicado: (2023)

Mathematical encounters of the second kind
por: Davis, Philip J
Publicado: (1996)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
por: Kityo, Cissy, et al.
Publicado: (2017)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Mathematical Modelling of Virus Spreading in COVID-19
por: Luo, Liaofu, et al.
Publicado: (2023)

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial
por: Kityo, Cissy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9eqcu53rko63d37ku84np4asp5